Skip to main content
Fig. 1 | BMC Medical Genetics

Fig. 1

From: Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort

Fig. 1

Sequence chromatograms of all novel mutations detected in BRCA1, BRCA2, TP53, and ERBB2 genes. a and b Forward and reverse strands sequence of pathogenic frameshift insertion mutation c.322dupG in TP53 gene. c and (d) Forward and reverse strands sequence of pathogenic missense mutation c.5011 T > C in BRCA1 gene. e and f Forward and reverse strands sequence of pathogenic frameshift deletion mutations c.351_352delTC in BRCA2 gene. g and h Forward and reverse strands sequence of pathogenic frameshift deletion mutationc.1301_1308del AAAGAAAG in BRCA2 gene. i and j Reverse strand sequence of missense mutation c.6451G > A and c.2272G > Cin BRCA2 and ERBB2 genes respectively

Back to article page